Received Mar 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TC3N5 | — |
Hiberix only diluent administered; Hiberix only diluent administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 14-month-old male patient who received Hib (Hiberix) (batch number TC3N5, expiry date 17-MAR-2026) for prophylaxis. On 17-MAR-2025, the patient received Hiberix. On 17-MAR-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix only diluent administered) and inappropriate dose of vaccine administered (Verbatim: Hiberix only diluent administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 17-MAR-2025 The nurse reported that on the reporting day only the diluent portion of the Hiberix vaccine was administered to a 14-month-old patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered The Vaccine Administration Facility is the same as Primary Reporter.